Application of nanocomposite coatings for multipotent mesenchymal stromal cells cultivation technologies

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The results of experimental research for the effect character of nanocomposite coatings with different physicochemical parameters on structural and functional properties (adhesive potential, phenotype, expression of ido gene) of multipotent mesenchymal stromal cells (MMSCs) are presented in the work. In the whole spectrum of tested nanocoatings (Al 2O 3, ZrO 2, Ta 2O 5) we have established the ability of oxide coating Al2O3 to monolayerly enrich the cultured in vitro bone marrow (BM) with the MMSCs and increase the degree of ido expression. This can expand the spectrum and give them new shapes of therapeutic potential in clinical practice.

Full Text

Restricted Access

About the authors

A. N Goltsev

Institute for Problems of Cryobiology and Cryomedicine of the NAS, Kharkov, Ukraine

I. V Rassokha

Institute for Problems of Cryobiology and Cryomedicine of the NAS, Kharkov, Ukraine

T. G Dubrava

Institute for Problems of Cryobiology and Cryomedicine of the NAS, Kharkov, Ukraine

L. V Ostankova

Institute for Problems of Cryobiology and Cryomedicine of the NAS, Kharkov, Ukraine

M. V Ostankov

Institute for Problems of Cryobiology and Cryomedicine of the NAS, Kharkov, Ukraine

E. A Gordienko

Institute for Problems of Cryobiology and Cryomedicine of the NAS, Kharkov, Ukraine

V. I Safonov

National Scientific Center «Kharkov Physico-Technical Institute» of the NAS, Kharkov, Ukraine

AV. V Zykova

National Scientific Center «Kharkov Physico-Technical Institute» of the NAS, Kharkov, Ukraine

References

  1. Щепкина Е.А. Кругляков П.В. Соломин Л.Н. и др. Клинический опыт трансплантации аутологичных мезенхимальных стволовых клеток при лечении ложных суставов длинных трубчатых костей. Травма 2007; 8 (3): 22—30.
  2. Parvizi J., Mehta S. Nanotechnology in Orthopaedic Surgery. US Musculoskeletal Review 2009; 4(1): 8—10.
  3. Webster T.J. Nanomedicine: what's in a definition? Nanomedicine 2006; 1(2): 169—76.
  4. Diener A., Nebe B., Uthen F.L. et al. Control of focal adhesion dynamics by material surface haracteristics. Biomaterials 2005; 26 (4): 383—92.
  5. Dalby M.J., Riehle M.O., Johnstone H.J.H. et at. Nonadhesive nanotopography: Fibroblast response to polytn-butyl methacrylate)— polytstyrene) demixed surface features. J. Biomed. Mater. Res. 2003; 67(3): 1025—32.
  6. Херрингтон С., Макги Д. Молекулярная клиническая диагностика. 1999. М.: Мир; 558.
  7. Safonov. V., A. Zykova., J.Smolik, et al. Nano scale biomaterial interface modifications for advanced tissue engineering applications. J. Physics. 2012; 356: 1—5.
  8. Baksh D., Song L., Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation and application in cell and gene therapy. J. Cell Mol. Med. 2004; 8 (3): 301—16.
  9. Simmons P.J., Masinovsky B., Longenecker B.M. et al. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992; 80(2): 388-95.
  10. Tzircotis G., Thorne R.F., Isacke C.M. Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding. J. Cell Sci. 2005; 118(21): 5119-28.
  11. Sanchez-Elsner T., Botella L.M., Velasco B. et al. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J. Biol. Chem. 2002; 277(46): 43799-808.
  12. Mellor A.L., Chandler P., Kook L.G. et al. Indoleamine 2.3-dioxygenase, immunosupression and pregnancy. J. Reprod. Immunol. 2002; 57(1-2): 143-50.
  13. Ball J.H., Yuasa J.H., Austin J.D.Ch. et al. Indoleamine 2.3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int. J. Biochem. Cell Biol. 2009; 41 (3): 467-71.
  14. Rombouts W.J.C., Ploemacher R.E. Nanotechnology in orthopaedic surgery. Leukemia 2003; 17 (1): 160-70.

Copyright (c) 2013 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 85657 от 21.07.2023 от 11.03.2014.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies